|
Summary:
Service Supply Of Infusion Systems And Related Consumables Country:
Italy Estimated Cost:
EUR 19706828 Notice Type:
Tender Notice Deadline:
24 Feb 2025 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Flupentixol, (Obg) Atc N05Af01 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Baricitinib, (Obo) Atc L04Aa37 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Mepolizumab, (Obo) Atc R03Dx09 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Lipegfilgrastim, (Obo) Atc L03Aa14 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Peg-Epoetin Beta, (Obo) Atc B03Xa03 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Flupentixol, (Obg) Atc N05Af01 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Baricitinib, (Obo) Atc L04Aa37 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Mepolizumab, (Obo) Atc R03Dx09 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
|
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Lipegfilgrastim, (Obo) Atc L03Aa14 For The Period 01.02.2025 - 31.01.2027 Country:
Germany Estimated Cost:
EUR 1 Notice Type:
Tender Notice Deadline:
04 Dec 2026 Posting Date:
16 Dec 2024 |
Company Health Services Tenders and Bids
Find company health services tenders and government contracts. Search for business opportunities for company health services tenders..
Healthcare and Medicine